Temasek’s Vertex leads Series B round for Clearbridge BioMedics
Vertex Ventures, a VC unit of Temasek Holdings, has led a Series B round of financing for Singapore-based Clearbridge BioMedics worth S$9 million ($7.2 million). Other participants include existing investor BioVeda, Spring Seeds Capital, Biosensors International founder Yoh-Chie Lu, and Clearbridge BSA, which is part of the Singapore government’s biomedical science accelerator initiative to encourage medical start-ups.
The capital will be used to develop Clearbridge's ClearCell System, used to detect, isolate and retrieve circulating tumor cells from blood. The technology aims to be the next generation of non-invasive...
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.